Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Pharmacology
  4. The N-formyl peptide receptors: contemporary roles in neuronal function and dysfunction

The N-formyl peptide receptors: contemporary roles in neuronal function and dysfunction

Neural Regeneration Research, 2020 · DOI: 10.4103/1673-5374.272566 · Published: January 9, 2020

PharmacologyImmunologyNeurology

Simple Explanation

N-formyl peptide receptors (FPRs) are a family of receptors that play a role in the body's defense and inflammation. They were initially found on phagocytic leukocytes, but research has revealed roles beyond the immune system. FPRs are expressed in neuronal tissues, especially in the central nervous system. Interactions between FPRs and endogenous ligands have been linked to the development of neurodegenerative diseases like Alzheimer’s and Parkinson’s, as well as neurological cancers. This review summarizes recent progress in understanding the role of FPRs in a neuronal setting and proposes them as a potential therapeutic target for nervous system conditions, potentially opening doors to novel neuronal regeneration therapies.

Study Duration
1975 to 2019
Participants
Humans and animals
Evidence Level
Review, in vivo and in vitro studies

Key Findings

  • 1
    FPRs are implicated in neurogenesis and neuronal differentiation, suggesting they could be a target for neuronal regeneration therapies.
  • 2
    FPRs can be exploited by primary tumors to escalate growth, as seen in neuroblastoma, where increased FPR1 tumor expression is correlated with low survival rates.
  • 3
    FPR2 can transduce both pro- and anti-inflammatory activity, suggesting multiple binding sites exploited by different agonists.

Research Summary

N-formyl peptide receptors (FPRs) were first identified upon phagocytic leukocytes, but more than four decades of research has unearthed a plethora of non-myeloid roles for this receptor family. Rapid developments in recent years have implicated FPRs in the process of neurogenesis and neuronal differentiation which, upon greater characterisation, could represent a novel pharmacological target for neuronal regeneration therapies that may be used in the treatment of brain/spinal cord injury, stroke and neurodegeneration. This review aims to summarize the recent progress made to determine the physiological role of FPRs in a neuronal setting, and to put forward a case for FPRs as a novel pharmacological target for conditions of the nervous system, and for their potential to open the door to novel neuronal regeneration therapies.

Practical Implications

Therapeutic Target for Neurodegenerative Diseases

FPRs could be a novel therapeutic target for future drug development, potentially reducing neurodegenerative disease progression by overcoming FPR-mediated inflammatory signaling.

Potential for Neuronal Regeneration Therapies

FPR transduction in neurogenesis could be exploited for NSCs to target areas of inflammation or damage in the nervous system and regenerate damaged neuronal tissue.

Neuropathic Pain Treatment

FPR antagonists could be administered to curtail undesirable neuronal differentiation and potentially halt neuroma formation, preventing neuropathic pain.

Study Limitations

  • 1
    Differences in FPR family members and ligand preferences between species may limit the extrapolation of murine NSC studies to humans.
  • 2
    The precise timing of microglial recruitment and activation during disease pathology remains unclear.
  • 3
    Limited animal experimentation targeting FPR for neuronal regeneration.

Your Feedback

Was this summary helpful?

Back to Pharmacology